The Cooper Companies, Inc. Common Stock (COO) Financial Statements
Historical financial data — 43 statements covering FY2016–FY2025
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of sp...
The Cooper Companies, Inc. Common Stock's revenue increased 5.1% year over year, from $3.90B to $4.09B.
Net income decreased 4.4% over the same period, from $392.3M to $374.9M.
Over the 9-year period from FY2016 to FY2025, revenue grew by 108% in total.
Total debt remained relatively stable at $2.51B.
The debt-to-equity ratio stands at 0.30, indicating a moderate leverage profile.
Operating cash flow grew 12.2% to $796.1M.
The Cooper Companies, Inc. Common Stock maintains a moderate net profit margin of 9.2%.
Recent Financial Statements
Quarterly figures are standalone quarters, de-cumulated from YTD filings (Q4 = FY − Q3 YTD when not reported).
| Period | Revenue | Net Income | Gross Profit | EBIT | Op. Cash Flow | Total Assets | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| Q4 FY2024 | $1.02B+1.6% | $117.5M | $677.7M | $198.4M | $268.1M | $12.32B | $2.58B | $8.08B |
| Q1 FY2025 | $964.7M-5.3% | $104.3M | $660.2M | $182.0M | $190.6M | $12.22B | $2.54B | $8.13B |
| Q2 FY2025 | $1.00B+3.9% | $87.7M | $679.1M | $184.8M | $96.2M | $12.41B | $2.59B | $8.29B |
| Q3 FY2025 | $1.06B+5.8% | $98.3M | $692.0M | $175.7M | $261.4M | $12.38B | $2.48B | $8.35B |
| Q4 FY2025 | $1.07B+0.5% | $84.6M | $650.8M | $140.4M | $247.9M | $12.39B | $2.51B | $8.24B |
| Q1 FY2026 | $1.02B-3.8% | $130.8M | $695.2M | $212.8M | $260.9M | $12.42B | $2.50B | $8.36B |
| Q2 FY2026 | $1.08B+5.6% | $-77.9M | $735.4M | $-31.0M | $182.8M | N/A | N/A | N/A |
| Q3 FY2026 | $1.07B-1.4% | $432.8M | $711.9M | $222.0M | $341.7M | N/A | N/A | N/A |
Balance Sheet Summary (Q1 FY2026)
The Cooper Companies, Inc. Common Stock (COO) Financial Statements & Revenue History
The Cooper Companies, Inc. Common Stock (COO) is a US-listed stock operating in the Healthcare sector, specifically the Ophthalmic Goods industry trading at $57.50 with a market capitalization of $11. This page provides 43 historical financial statements for The Cooper Companies, Inc. Common Stock, including income statement, balance sheet, and cash flow data across multiple reporting periods. Most recently, The Cooper Companies, Inc. Common Stock reported revenue of $4.1 billion, representing 5.1% year-over-year growth. The net profit margin of 9.2% indicates moderate profitability. The debt-to-equity ratio of 0.30 shows conservative leverage.
COO Income Statement, Balance Sheet & Cash Flow
The financial statements table above shows The Cooper Companies, Inc. Common Stock's revenue, net income, gross profit, EBIT, operating cash flow, total assets, total debt, and shareholders' equity across the most recent reporting periods. Year-over-year growth rates help identify whether COO is accelerating or decelerating in terms of top-line revenue and bottom-line profitability.
- Revenue trend: Track COO's top-line growth across quarters and fiscal years to identify acceleration or deceleration in the business.
- Profitability: Net income and gross profit margins reveal how efficiently The Cooper Companies, Inc. Common Stock converts revenue into earnings.
- Balance sheet health: Total assets, liabilities, debt, and equity provide a snapshot of COO's financial position and leverage.
- Cash flow: Operating cash flow shows how much cash the business generates from its core operations, which is critical for funding dividends, buybacks, and growth.
How to Use COO Financial Data
Investors use The Cooper Companies, Inc. Common Stock's financial statements to assess the company's financial health, growth trajectory, and valuation. Key metrics to focus on include:
- Revenue growth rate: Consistent double-digit revenue growth suggests a strong business; declining revenue may signal competitive pressure.
- Net profit margin: Higher margins indicate a more efficient business with pricing power. Compare COO's margins to sector peers for context.
- Debt levels: High debt-to-equity ratios increase financial risk, especially in rising-rate environments. Low debt provides flexibility.
- Valuation multiples: See how COO's P/E, P/S, and EV/EBITDA ratios compare to historical levels.
- Full analysis: View COO's financial health score, earnings, and pre-market pricing.
Financial data is sourced from The Cooper Companies, Inc. Common Stock's SEC filings (10-K, 10-Q) via Polygon.io and Finnhub.COO trades on NYSE/NASDAQ. This page is for informational purposes only and is not financial advice.